Envestnet Asset Management Inc Intellia Therapeutics, Inc. Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

A detailed history of Envestnet Asset Management Inc transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 79,977 shares of NTLA stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

79,977

Previous 55,556 43.96%

Holding current value

$1.12 Million

Previous $1.24 Million 32.18%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$19.72 - $27.36 $481,582 - $668,158	24,421 Added 43.96%	79,977 $1.64 Million
Q2 2024 Aug 08, 2024	BUY	$20.02 - $27.22 $85,365 - $116,066	4,264 Added 8.31%	55,556 $1.24 Million
Q1 2024 May 13, 2024	BUY	$23.82 - $32.8 $48,497 - $66,780	2,036 Added 4.13%	51,292 $1.41 Million
Q4 2023 Feb 13, 2024	BUY	$23.16 - $32.34 $289,476 - $404,217	12,499 Added 34.0%	49,256 $1.5 Million
Q3 2023 Nov 13, 2023	BUY	$31.62 - $45.78 $553,350 - $801,150	17,500 Added 90.88%	36,757 $1.16 Million
Q2 2023 Aug 04, 2023	SELL	$34.58 - $46.03 $8,437 - $11,231	-244 Reduced 1.25%	19,257 $785,000
Q1 2023 May 11, 2023	BUY	$33.3 - $44.82 $32,201 - $43,340	967 Added 5.22%	19,501 $726,000
Q4 2022 Feb 07, 2023	SELL	$33.21 - $62.69 $80,368 - $151,709	-2,420 Reduced 11.55%	18,534 $646,000
Q3 2022 Nov 10, 2022	SELL	$53.92 - $71.7 $19,734 - $26,242	-366 Reduced 1.72%	20,954 $1.17 Million
Q2 2022 Aug 03, 2022	SELL	$38.49 - $76.21 $9,083 - $17,985	-236 Reduced 1.09%	21,320 $1.1 Million
Q1 2022 May 04, 2022	SELL	$58.27 - $118.99 $214,200 - $437,407	-3,676 Reduced 14.57%	21,556 $1.57 Million
Q4 2021 Feb 04, 2022	BUY	$100.76 - $138.36 $320,517 - $440,123	3,181 Added 14.43%	25,232 $2.98 Million
Q3 2021 Oct 07, 2021	BUY	$132.37 - $176.78 $101,792 - $135,943	769 Added 3.61%	22,051 $2.96 Million
Q2 2021 Aug 04, 2021	SELL	$60.88 - $161.91 $82,735 - $220,035	-1,359 Reduced 6.0%	21,282 $3.45 Million
Q1 2021 May 04, 2021	BUY	$46.59 - $83.68 $336,053 - $603,583	7,213 Added 46.75%	22,641 $1.82 Million
Q4 2020 Feb 02, 2021	BUY	$18.83 - $63.53 $290,509 - $980,140	15,428 New	15,428 $839,000

Others Institutions Holding NTLA

# of Institutions

313

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.06B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Intellia Therapeutics, Inc. Transaction History